A collection of news and information related to Vertex Pharmaceuticals Incorporated published by this site and its partners.
Displaying items 1-12 of 12 » View wsbtradio.com items only
ReutersBy Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...
Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...
ReutersMay 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including Berkshire Hathaway, Aetna and Fortinet Inc on Wednesday. HIGHLIGHTS * Aetna Inc : Credit Suisse, Jefferies, Susquehanna, others...
ReutersApril 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company raised its forecast for sales of a cystic fibrosis drug...
READER SUBMITTED: American Liver Foundation's Raises $242,000 At Twelfth Annual Flavors Of ConnecticutStatewideThe American Liver Foundation (ALF), a non-profit organization focused on promoting liver health and disease prevention held its annual fundraising event, Flavors of Connecticut presented by Hartford Hospital. The event took place on April 9 at the Aqua...
ReutersApril 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Microsoft, Google and IBM, on Friday. HIGHLIGHTS * Apple : Barclays cuts price target to $465 from $530 - Theflyonthewall....
Reuters* GE meets expectations, shares dip * IBM shares down, Google up after results * Futures up: Dow 77 pts, S&P 10 pts, Nasdaq 14 pts NEW YORK, April 19 (Reuters) - U.S. stock index futures rose on Friday, setting the market up for a bounce back a day...
Anewly formed infectious disease clinic in Lynchburg, VA is bringing expert medical care to those in the area with hepatitis C. An estimated 3.2 million people in the United States have a chronic hepatitis C viral infection. Most of them don’t even...
Tags: Pharmaceuticals, Disease Prevention, Hepatitis C , Liver Disease, Flu
ATLANTA (AP) — For the first time, the government is proposing that all baby boomers get tested for hepatitis C. Anyone born from 1945 to 1965 should get a one-time blood test to see if they have the liver-destroying virus, the Centers for...
WASHINGTON (AP)— Deaths from liver-destroying hepatitis C are on the rise, and new data shows baby boomers especially should take heed — they are most at risk. Federal health officials are considering whether anyone born between 1945 and 1965...
All her life, Lindsay Shipp knew that she was dying. As a baby, she would cry after eating, and salt collected on her forehead. The diagnosis was cystic fibrosis, an incurable genetic disease that, at the time, meant a life expectancy of 18 years. The...
ReutersVertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co. Incivek, a pill...
May 8, 2013 |Story| Reuters
May 2, 2013 |Story| South Florida Sun-Sentinel
May 1, 2013 |Story| Reuters
Apr 30, 2013 |Story| Reuters
Apr 28, 2013 |Story| Hartford Courant
Apr 19, 2013 |Story| Reuters
Apr 19, 2013 |Story| Reuters
Aug 27, 2012 |Story| WDBJ7
May 18, 2012 |Story| AP Broadcast
Feb 21, 2012 |Story| Petoskey News
Nov 2, 2011 |Story| Los Angeles Times
May 23, 2011 |Story| Reuters
Original site for Vertex Pharmaceuticals Incorporated topic gallery.